{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:14:28Z","timestamp":1756901668127,"version":"3.44.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human immunodeficiency virus (HIV)-associated lipodystrophy is a well-recognized complication of long-term antiretroviral therapy (ART), characterized by abnormal fat distribution. In the head and neck, it typically present as an obtuse heavy neck combined with accelerated midfacial atrophy, causing significant aesthetic concerns and psychosocial distress. Conventional treatments, including ART modifications, have limited effectiveness, and changes are often irreversible. We present a novel surgical approach, a modified facelift, to manage facial lipodystrophy in a 57-year-old HIV-positive man. Following unsuccessful non-surgical interventions, the facelift provided substantial aesthetic improvements and addressed functional concerns associated with coincidental Frey\u2019s syndrome. Postoperative recovery was uneventful, and at 6-month follow-up, the patient reported sustained aesthetic satisfaction and significant symptomatic improvement. This case demonstrates that a modified facelift is a promising low-morbidity surgical option for addressing complex facial lipodystrophy in HIV patients, offering durable cosmetic and functional outcomes where traditional methods have failed.<\/jats:p>","DOI":"10.1093\/jscr\/rjaf683","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:55:34Z","timestamp":1756788934000},"source":"Crossref","is-referenced-by-count":0,"title":["Facelift as a novel surgical treatment for HIV-associated facial lipodystrophy: a case report and literature review"],"prefix":"10.1093","volume":"2025","author":[{"given":"Daniyal","family":"Ashraf","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge , Cambridge CB2 0SP, Cambridgeshire ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rushabh","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ, Cambridgeshire ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taj","family":"Tomouk","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ, Cambridgeshire ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ, Cambridgeshire ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"2025090200552519300_ref1","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ekir.2018.04.014","article-title":"Lipodystrophy increases the risk of CKD development in HIV-positive patients in Switzerland: the LIPOKID study","volume":"3","author":"Bouatou","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2025090200552519300_ref2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1590\/1980-5497201700030014","article-title":"Body fat redistribution and changes in lipid and glucose metabolism in people living with HIV\/AIDS","volume":"20","author":"Beraldo","year":"2017","journal-title":"Rev Bras Epidemiol"},{"key":"2025090200552519300_ref3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/hsc.12459","article-title":"\"I don't want to look like an AIDS victim\": a New Zealand case study of facial lipoatrophy","volume":"26","author":"Abel","year":"2018","journal-title":"Health Soc Care Commun"},{"key":"2025090200552519300_ref4","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/01.aids.0000191485.92285.c7","article-title":"Self-perception of body changes in persons living with HIV\/AIDS: prevalence and associated factors","volume":"19","author":"Santos","year":"2005","journal-title":"AIDS"},{"key":"2025090200552519300_ref5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QCO.0b013e3283420eef","article-title":"Pathogenesis and treatment of HIV lipohypertrophy","volume":"24","author":"Leung","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"2025090200552519300_ref6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3851\/IMP2083","article-title":"A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity","volume":"17","author":"Moyle","year":"2012","journal-title":"Antivir Ther"},{"key":"2025090200552519300_ref7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/QAD.0b013e32834f3507","article-title":"Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy","volume":"26","author":"Curran","year":"2012","journal-title":"AIDS"},{"key":"2025090200552519300_ref8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bjps.2007.11.014","article-title":"Plastic surgical options for HIV-associated lipodystrophy","volume":"61","author":"Nelson","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025090200552519300_ref9","doi-asserted-by":"publisher","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"2025090200552519300_ref10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2147\/TCRM.S35075","article-title":"HIV-associated lipodystrophy: a review from a Brazilian perspective","volume":"10","author":"Alves","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"2025090200552519300_ref11","doi-asserted-by":"publisher","first-page":"19033","DOI":"10.7448\/IAS.18.1.19033","article-title":"HIV\/AIDS and lipodystrophy: implications for clinical management in resource-limited settings","volume":"18","author":"Finkelstein","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"2025090200552519300_ref12","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"2025090200552519300_ref13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2147\/CCID.S266015","article-title":"Effect of hyaluronic acid and poly-L-lactic acid dermal fillers on collagen synthesis: an in vitro and in vivo study","volume":"13","author":"Cabral","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"author":"Kustermans","key":"2025090200552519300_ref14","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2169803\/v1"},{"key":"2025090200552519300_ref15","first-page":"486","article-title":"Treatment of facial lipoatrophy via autologous fat transfer","volume":"8","author":"Cohen","year":"2009","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jscr\/article-pdf\/2025\/9\/rjaf683\/64182974\/rjaf683.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jscr\/article-pdf\/2025\/9\/rjaf683\/64182974\/rjaf683.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:55:34Z","timestamp":1756788934000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jscr\/article\/doi\/10.1093\/jscr\/rjaf683\/8245409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jscr\/rjaf683","relation":{},"ISSN":["2042-8812"],"issn-type":[{"type":"electronic","value":"2042-8812"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9,1]]},"article-number":"rjaf683"}}